Manufacture

Cell and gene therapy manufacturing technologies and methods are advancing rapidly, but can regulators keep up?

Biocatalysis is an increasingly attractive option in pharmaceutical synthesis.

The increasing complexity of biologics raises significant manufacturing challenges – not least regarding cost control and downstream purification.

We Sit Down With Sandy Macrae, Chief Executive Officer, Sangamo Therapeutics, USA.

Everything cell + gene therapy – in five minutes.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

Big Data opens the door to even smarter cell therapies.

A decade-long AAV gene therapy study in dogs emphasizes the importance of long-term follow up.

Tissue engineers combine plant and human cells for biomedical applications.

Key opinion leaders share their views on the importance of ATMP scale up.